凯胺用于治疗严重抑郁症:系统性审查和元分析
Stevan Nikolin1,2, Anthony Rodgers3, Andreas Schwaab4
1Discipline of Psychiatry and Mental Health, University of New South Wales, Sydney, Australia.
EClinicalMedicine
|August 18, 2023
概括
这次元分析发现,在抑郁症治疗中,racemic ketamine比esketamine更有效,更高的剂量显示出更大的疗效. 在治疗期间和最后一剂后,立即观察到效果.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 鼻腔内注射的埃斯基坦胺已被批准用于治疗抑郁症.
- 最近的试验表明,赛血基胺在重度抑郁症中有效.
- 对于胺治疗的比较疗效,最佳剂量和反应时间仍不清楚.
研究的目的:
- 系统地审查和对抑郁症胺的随机对照试验 (RCT) 进行元分析.
- 为了比较racemic ketamine与esketamine的疗效.
- 为了研究剂量和治疗时间对胺有效性的影响.
主要方法:
- 在2023年4月13日之前对Embase,Medline,Pubmed,PsycINFO和CENTRAL数据库进行系统搜索.
- 包括49个RCT与3299名参与者,评估抑郁症的严重程度,反应,缓解和放弃.
- 超回归分析将药物配方 (racemic与esketamine) 和剂量 (低与高) 作为共同变量.
主要成果:
- 对于所有胺配方和剂量的第一剂后,抑郁症严重程度的影响大小为中度至高.
- 拉塞米克胺在重复服用期间和重复服用后,与胺相比,持续性和持久性效应显著增加.
- 较高剂量的胺与较低剂量的疗效相比,效果更大,在所有原因中断率上没有显著差异.
结论:
- 在治疗抑郁症方面, Racemic 胺似乎比 esketamine 更有效,特别是在更高剂量的情况下.
- 赛血基胺的好处超出了初始治疗的范围,显示了持续的效果.
- 进一步的研究应该专注于优化胺配方和剂量用于抑郁症治疗.
相关概念视频
Electroconvulsive Therapy
69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Sedatives and Hypnotics Drugs: Miscellaneous Agents
202
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
202
Parenteral Anesthetics: Overview
154
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
154
Antidepressant Drugs: MAOIs and Other Agents
272
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
272
Drug Therapy
68
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
68
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
435
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
435


